Here’s our fortnightly wrap of all the news driving ASX health stocks.

Of the ASX’s 137-odd small cap health stocks, 61 were in positive territory over the last fortnight, 10 were flat and 66 saw their share prices fall.

Code Name Price $ (April 15) 2 week return % 1 year return % Market cap
AVE AVECHO BIOTECHNOLOGY LTD 0.008 60 100 $12,779,659
APH AUSTRALIAN PRIMARY HEMP LTD 0.125 57 -50 $7,673,065
ADR ADHERIUM LTD 0.035 54 6 $18,390,634
FTT FACTOR THERAPEUTICS LTD 0.003 50 -33 $3,128,507
JHL JAYEX HEALTHCARE LTD 0.023 38 -37 $3,879,987
OIL OPTISCAN IMAGING LTD 0.041 37 3 $19,588,930
1AD ADALTA LTD 0.061 36 -66 $9,836,737
CP1 CANNPAL ANIMAL THERAPEUTICS 0.1 30 -25 $9,778,125
IMM IMMUTEP LTD 0.175 30 -37 $68,535,416
RCE RECCE PHARMACEUTICALS LTD 0.415 27 70 $54,228,716
GLH GLOBAL HEALTH LTD 0.145 26 11 $6,104,257
NYR NYRADA INC-CDI 0.175 25 -23 $19,142,152
DXB DIMERIX LTD 0.185 23 110 $33,582,444
DVL DORSAVI LTD 0.017 21 -71 $3,934,268
CDX CARDIEX LTD 0.021 21 -39 $17,323,814
PAA PHARMAUST LTD 0.105 20 186 $30,202,106
1ST 1ST GROUP LTD 0.03 19 -35 $13,587,741
OSX OSTEOPORE LTD 0.515 15 157 $53,146,012
IMC IMMURON LTD 0.098 15 -56 $16,304,093
SVA SIMAVITA LTD-CDI 0.023 15 35 $12,966,897
NEU NEUREN PHARMACEUTICALS LTD 1.55 14 27 $158,365,984
MEM MEMPHASYS LTD 0.049 14 113 $36,944,720
MDC MEDLAB CLINICAL LTD 0.25 14 -32 $58,305,452
CMP COMPUMEDICS LTD 0.49 13 1 $85,924,032
IVX INVION LTD 0.009 13 -53 $49,505,456
RHT RESONANCE HEALTH LTD 0.145 12 12 $62,128,352
IPD IMPEDIMED LTD 0.039 11 -85 $30,409,448
ONE ONEVIEW HEALTHCARE PLC-CDI 0.063 11 -79 $10,219,477
CTE CRYOSITE LTD 0.08 11 122 $3,748,765
ATH ALTERITY THERAPEUTICS LTD 0.02 11 -51 $17,988,258
S66 STAR COMBO PHARMA LTD 0.45 10 -33 $38,941,472
IBX IMAGION BIOSYSTEMS LTD 0.013 9 -57 $9,137,162
ANR ANATARA LIFESCIENCES LTD 0.19 9 -59 $9,472,674
UBI UNIVERSAL BIOSENSORS INC-CDI 0.195 8 -9 $34,626,512
ELX ELLEX MEDICAL LASERS LTD 0.6 8 2 $86,160,680
LCT LIVING CELL TECHNOLOGIES LTD 0.014 8 -63 $8,000,174
PAB PATRYS LTD 0.014 8 -39 $15,016,265
PAL PALLA PHARMA LTD 0.61 7 -49 $76,828,264
FFC FARMAFORCE LTD 0.08 7 0 $10,301,678
PGC PARAGON CARE LTD 0.16 6 -62 $57,440,500
MDR MEDADVISOR LTD 0.44 6 16 $108,337,256
OVN OVENTUS MEDICAL LTD 0.285 6 23 $37,200,968
ACW ACTINOGEN MEDICAL LTD 0.021 5 -60 $23,440,858
PTX PRESCIENT THERAPEUTICS LTD 0.046 5 -2 $17,347,468
AZV AZURE HEALTHCARE LTD 0.067 5 -5 $19,040,660
BOT BOTANIX PHARMACEUTICALS LTD 0.047 5 -55 $43,771,412
BLT BENITEC BIOPHARMA LTD 0.026 4 -79 $8,353,463
MMJ MMJ GROUP HOLDINGS LTD 0.13 4 -41 $31,043,788
ADO ANTEOTECH LTD 0.027 4 60 $44,390,264
PIQ PROTEOMICS INTERNATIONAL LAB 0.305 4 5 $26,645,454
CAN CANN GROUP LTD 0.915 3 -63 $126,884,696
RAP RESAPP HEALTH LTD 0.18 3 0 $130,685,144
OPT OPTHEA LTD 2.44 3 239 $637,903,936
TLX TELIX PHARMACEUTICALS LTD 1.23 2 32 $301,599,360
EXL ELIXINOL GLOBAL LTD 0.385 1 -92 $52,399,764
AHX APIAM ANIMAL HEALTH LTD 0.415 1 -6 $48,387,812
JHC JAPARA HEALTHCARE LTD 0.5 1 -64 $132,287,424
M7T MACH7 TECHNOLOGIES LTD 0.56 1 109 $101,470,168
PSQ PACIFIC SMILES GROUP LTD 1.19 1 5 $180,872,144
HLA HEALTHIA LTD 0.7 1 -26 $44,124,256
SOM SOMNOMED LTD 1.155 0 -27 $94,928,080
IDT IDT AUSTRALIA LTD 0.15 0 -3 $35,896,956
ALT ANALYTICA LTD 0.002 0 -50 $7,039,225
CGS COGSTATE LTD 0.345 0 58 $58,665,580
ONT 1300 SMILES LTD 5.1 0 -16 $120,759,760
IMU IMUGENE LTD 0.026 0 39 $110,649,264
GTG GENETIC TECHNOLOGIES LTD 0.005 0 -18 $25,568,898
GMV G MEDICAL INNOVATION HOLDING 0.105 0 -66 $59,410,916
RGS REGENEUS LTD 0.068 0 -37 $18,892,100
GSS GENETIC SIGNATURES LTD 1.85 0 62 $263,811,840
AGH ALTHEA GROUP HOLDINGS LTD 0.375 -1 -24 $86,907,976
PBP PROBIOTEC LTD 1.97 -1 33 $147,314,368
RNO RHINOMED LTD 0.08 -1 -64 $13,367,275
THC THC GLOBAL GROUP LTD 0.32 -2 -39 $44,342,404
PCK PAINCHEK LTD 0.11 -2 216 $111,318,656
NOX NOXOPHARM LTD 0.205 -2 -64 $30,457,230
AC8 AUSCANN GROUP HOLDINGS LTD 0.2 -3 -47 $61,824,236
CAJ CAPITOL HEALTH LTD 0.19 -3 -26 $182,418,928
PNV POLYNOVO LTD 2.08 -3 110 $1,394,895,744
SDI SDI LTD 0.72 -3 -13 $84,988,856
ACR ACRUX LTD 0.14 -3 -36 $23,595,392
BWX BWX LTD 3.31 -4 50 $410,024,640
RAC RACE ONCOLOGY LTD 0.28 -4 342 $30,632,002
ATX AMPLIA THERAPEUTICS LTD 0.077 -4 -38 $5,117,665
ICS ICSGLOBAL LTD 1.7 -4 72 $18,026,832
BD1 BARD1 LIFE SCIENCES LTD 0.025 -4 34 $32,812,440
MVP MEDICAL DEVELOPMENTS INTERNA 7.55 -4 36 $492,176,192
BIT BIOTRON LTD 0.1 -5 25 $70,193,272
SKN SKIN ELEMENTS LTD 0.075 -5 107 $24,776,162
VLS VITA LIFE SCIENCES LTD 0.57 -5 -16 $30,827,088
NXS NEXT SCIENCE LTD 1.7 -5 1 $307,483,872
SDX SIENNA CANCER DIAGNOSTICS LT 0.053 -5 -12 $20,942,040
ALC ALCIDION GROUP LTD 0.165 -6 98 $168,417,984
CYC CYCLOPHARM LTD 1.32 -6 8 $103,274,688
VBS VECTUS BIOSYSTEMS LTD 0.49 -6 18 $11,590,860
HCT HOLISTA COLLTECH LTD 0.155 -6 128 $42,679,108
ANP ANTISENSE THERAPEUTICS LTD 0.048 -6 -10 $22,484,122
SUD SUDA PHARMACEUTICALS LTD 0.046 -6 -45 $6,543,703
ZLD ZELIRA THERAPEUTICS LTD 0.046 -6 10 $44,736,308
EHH EAGLE HEALTH HOLDINGS LTD 0.14 -7 -51 $51,606,324
KZA KAZIA THERAPEUTICS LTD 0.41 -7 -16 $36,985,420
SCU STEMCELL UNITED LTD 0.013 -7 -24 $8,340,909
NC6 NANOLLOSE LTD 0.022 -8 -64 $1,650,000
PYC PYC THERAPEUTICS LTD 0.074 -9 204 $213,994,240
PXS PHARMAXIS LTD 0.089 -10 -70 $35,553,032
NSB NEUROSCIENTIFIC BIOPHARMACEU 0.175 -10 9 $13,717,302
RHY RHYTHM BIOSCIENCES LTD 0.086 -10 -54 $8,664,500
PAR PARADIGM BIOPHARMACEUTICALS 1.73 -11 8 $379,805,824
OSP OSPREY MEDICAL INC-CDI 0.012 -12 -92 $6,261,062
TD1 TALI DIGITAL LTD 0.031 -12 58 $22,479,156
OSL ONCOSIL MEDICAL LTD 0.11 -12 108 $68,260,312
OCC ORTHOCELL LTD 0.31 -13 163 $58,180,096
ZNO ZOONO GROUP LTD 1.67 -13 1842 $272,732,224
LBT LBT INNOVATIONS LTD 0.105 -13 25 $23,553,978
IHL IMPRESSION HEALTHCARE LTD 0.052 -13 126 $37,305,628
CDY CELLMID LTD 0.215 -14 10 $26,251,310
MVF MONASH IVF GROUP LTD 0.575 -14 -43 $133,566,904
MEB MEDIBIO LTD 0.006 -14 -67 $5,970,780
VHT VOLPARA HEALTH TECHNOLOGIES 1.2875 -15 -35 $302,423,232
AVH AVITA MEDICAL LTD 0.46 -15 21 $981,380,032
CYP CYNATA THERAPEUTICS LTD 0.67 -16 -44 $72,581,256
VTI VISIONEERING TECH-CDI 0.016 -18 -79 $10,713,442
BNO BIONOMICS LTD 0.045 -18 -67 $24,510,864
MX1 MICRO-X LTD 0.14 -18 -57 $43,752,864
BPH BPH ENERGY LTD 0.008 -20 -20 $2,673,171
ESE ESENSE-LAB LTD-CDI 0.008 -20 -67 $1,520,615
AMT ALLEGRA ORTHOPAEDICS LTD 0.125 -20 20 $11,947,086
RSH RESPIRI LTD 0.068 -22 -30 $39,869,036
CPH CRESO PHARMA LTD 0.068 -26 -86 $14,600,423
UCM USCOM LTD 0.22 -28 32 $30,680,116
BXN BIOXYNE LTD 0.01 -33 -47 $6,401,454
LSH LIFESPOT HEALTH LTD 0.03 -43 -53 $2,630,920
MXC MGC PHARMACEUTICALS LTD 0.028 71 -37 $41,895,896

 

While mergers and acquisitions in Asia have stalled, due to concerns around instability caused by the COVID-19 pandemic, healthcare service deals are going ahead in Australia.

Australian healthcare deals that are imminent or under negotiation are more likely to proceed, as compared to deals in other sectors, information consultancy Mergermarket said.

It said medical centres and hospitals, pathology and diagnostics companies, healthcare technology businesses, and suppliers of drugs, vitamins and other products that can help manage the pandemic are some areas where deals are more likely to take place.

Coming under pressure will be discretionary healthcare like cosmetics and aged care services providers.

 

Biggest movers

The biggest mover over the last fortnight was MGC Pharma (ASX:MXC) which said it received ethics approval from a second hospital in Israel to run a phase II clinical trial on COVID-19 patients.

Avecho (ASX:AVE), fresh off announcing it was moving into pot, gained a new CEO, did a marijuana supply deal with secretive Tasmanian company Tasmanian Alkaloids, and reported $194,000 in receipts during the March quarter.

Asthma medication monitor Adherium (ASX:ADR) secured a new CEO in Mike Motion and signed a sales agreement with Monaghan Medical Corporation, a US subsidiary of multinational Trudell Medical. The agreement covers specialty sales and comes after news of a collaboration with disease management group HGE Health.

Healthcare software company Jayex (ASX:JHL) rose after booking strong March quarter receipts but no one including the board, is clear on why Optiscan (ASX:OIL) stock is rising.

Cancer hopeful Immutep (ASX:IMM) released more data from its ongoing phase II TACTI-002 study.

The data it is producing shows continued efficacy data for patients with non-small cell lung cancer, with overall progression-free survival now at eight months and counting. Almost three quarters of patients have seen their tumours shrink.

 

News you can use (to invest)

In the two months to March 29, 493 clinical trials in Australia alone have been pulled as COVID-19 infection fears mean only the most critical trials are allowed to continue.

This has big implications for not only future drugs, but people who might have been able to be treated in a clinical trial now and won’t in the future because their illness has progressed too far.

Do you invest on the back of regulatory approval announcements? Stop, read this first.

If the company hasn’t lined all of its ducks up in a tidy row before getting a regulatory tick for its device, you may be stuck with a company with a device it can’t sell.